1. 2019
  2. Iodinated anti-HER2 sdAb effectively targets and treats HER2 positive brain lesions

    Puttemans, J., D'Huyvetter, M., Lahoutte, T. & Devoogdt, N., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  3. Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

    Puttemans, J., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 1 Aug 2019, In : Pharmaceutics. 11, 8, 23 p., 376.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  4. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Back, T., Aneheim, E., Jensen, H., Puttemans, J., Xavier, C., Keyaerts, M., Palm, S., Albertsson, P., Lahoutte, T., Caveliers, V., Lindegren, S. & D'Huyvetter, M., Aug 2019, In : Molecular Pharmaceutics. 16, 8, p. 3524-3533

    Research output: Contribution to journalArticleResearchpeer-review

  5. CAM-H2 effectively targets and treats HER2 positive brain lesions: a comparative preclinical study with Trastuzumab.

    Puttemans, J., D'Huyvetter, M., Windhorst, AD., Lahoutte, T. & Devoogdt, N., 2 May 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  6. Fluorescence-guided surgery of brain tumors using Nanobodies

    Puttemans, J., Arslan, A., Debie, P., Devoogdt, N. & Hernot, S., 20 Mar 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  7. 2018
  8. Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model

    Debie, P., Vanhoeij, M., Poortmans, N., Puttemans, J., Gillis, K., Devoogdt, N., Lahoutte, T. & Hernot, S., Jun 2018, In : Molecular Imaging and Biology. 20, 3, p. 361-367 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. 2017
  10. Radiolabeled Nanobodies Targeting Brain Tumors and Metastases

    Puttemans, J., Muyldermans, S., D'Huyvetter, M. & Devoogdt, N., 28 Mar 2017.

    Research output: Unpublished contribution to conferencePosterResearch

  11. 2016
  12. 131I-labeled anti-HER2 nanobody as a theranostic tool in cancer treatment

    D'Huyvetter, M., De Vos, J., Puttemans, J., Krasniqi, A., Xavier, C., Raes, G., Devoogdt, N., Zalutsky, M. & Lahoutte, T., 10 Sep 2016.

    Research output: Unpublished contribution to conferenceUnpublished abstractResearch

  13. Targeting brain tumors and metastases using radiolabeled nanobodies

    Puttemans, J., D'Huyvetter, M., Muyldermans, S., Lahoutte, T. & Devoogdt, N., 8 Sep 2016.

    Research output: Unpublished contribution to conferencePosterResearch

Previous 1 2 Next

ID: 11130341